Dil has informed that a meeting of the Audit Committee and Board of Directors of the Company is scheduled to be held on August 14, 2015, to consider and approve unaudited financial results (Standalone and Consolidated) of the Company for the quarter ended June 30, 2015. Further, in compliance with the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 and the Company’s Code of Conduct to Regulate, Monitor and Report Trading by Insiders, it is hereby notified that ‘Trading Window’ (period for trading in Company’s securities) shall be closed from August 06,2015 till expiry of 24 hours from the close of business hours on the date of the ensuing Board Meeting to be held on August 14, 2015, for approval of the unaudited financial results (Standalone and Consolidated) of the Company, for the quarter ended June 30,2015. During the closure of Trading Window, all Directors, Promoters, Insiders, Designated Persons including Auditors shall not, directly or indirectly trade or deal or enter into any transaction involving sale or purchase of the Company’s Equity Shares, either in their own name or in the name of their Immediate Relatives.
The above information is a part of company’s filings submitted to BSE.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1804.50 |
Dr. Reddys Lab | 1201.45 |
Cipla | 1551.30 |
Lupin | 2104.90 |
Zydus Lifesciences | 879.85 |
View more.. |